Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Banerjee, Debasish (57198042923)"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC
    (2024)
    Savarese, Gianluigi (36189499900)
    ;
    Lindberg, Felix (57451813800)
    ;
    Cannata, Antonio (56950331100)
    ;
    Chioncel, Ovidiu (12769077100)
    ;
    Stolfo, Davide (31067487400)
    ;
    Musella, Francesca (37061599500)
    ;
    Tomasoni, Daniela (57214231971)
    ;
    Abdelhamid, Magdy (57069808700)
    ;
    Banerjee, Debasish (57198042923)
    ;
    Bayes-Genis, Antoni (58760048400)
    ;
    Berthelot, Emmanuelle (25921922700)
    ;
    Braunschweig, Frieder (6602194306)
    ;
    Coats, Andrew J.S. (35395386900)
    ;
    Girerd, Nicolas (23027379700)
    ;
    Jankowska, Ewa A. (21640520500)
    ;
    Hill, Loreena (56572076500)
    ;
    Lainscak, Mitja (9739432000)
    ;
    Lopatin, Yury (59263990100)
    ;
    Lund, Lars H. (7102206508)
    ;
    Maggioni, Aldo P. (57203255222)
    ;
    Moura, Brenda (6602544591)
    ;
    Rakisheva, Amina (58038558000)
    ;
    Ray, Robin (57194275026)
    ;
    Seferovic, Petar M. (55873742100)
    ;
    Skouri, Hadi (21934953600)
    ;
    Vitale, Cristiana (7005091702)
    ;
    Volterrani, Maurizio (7004062259)
    ;
    Metra, Marco (7006770735)
    ;
    Rosano, Giuseppe M.C. (59142922200)
    Guideline-directed medical therapy (GDMT) in patients with heart failure and reduced ejection fraction (HFrEF) reduces morbidity and mortality, but its implementation is often poor in daily clinical practice. Barriers to implementation include clinical and organizational factors that might contribute to clinical inertia, i.e. avoidance/delay of recommended treatment initiation/optimization. The spectrum of strategies that might be applied to foster GDMT implementation is wide, and involves the organizational set-up of heart failure care pathways, tailored drug initiation/optimization strategies increasing the chance of successful implementation, digital tools/telehealth interventions, educational activities and strategies targeting patient/physician awareness, and use of quality registries. This scientific statement by the Heart Failure Association of the ESC provides an overview of the current state of GDMT implementation in HFrEF, clinical and organizational barriers to implementation, and aims at suggesting a comprehensive framework on how to overcome clinical inertia and ultimately improve implementation of GDMT in HFrEF based on up-to-date evidence. © 2024 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback